Total: $83.771M

Company (Symbol)#

Type Of Financing

Number Of Shares, Units Or Warrants (M)

AmountRaised (M)

Investors; Placement Agents; Details (Date)@

BioTime Inc.(AMEX:BTX)

Private placement of common stock

1.8S

$2

BioTime raised about $2M in a private placementof about 1.8M shares through Ladenburg Thalmann & Co. Inc. (8/13)

Cepheid Inc.(CPHD)

Private placement of common stock

4S

$10

Cepheid raised $10M net in a sale of common stock to certain investors (8/2)

Corixa Corp. (CRXA)

Private placement of common stock

7.3S

$45

Corixa raised about $45M in a private placement of 7.3M shares; the financing was led by InterWest Partners; other investors were BankAmerica Ventures, Hambrecht & Quist Capital Management LLC, KBL Healthcare Ventures, Oxford Bioscience Partners and Sutter Hill Ventures; the placement agent was Pacific Growth Equities Inc. (8/12)

Interferon Sciences Inc. (OTC BB:IFSC)

Private placement of convertible notes

N/A

$0.5

Interferon completed a private placement of $500,000 in convertible notes to accredited investors (8/14)

Miravant Medical Technologies Inc. (OTC BB:MRVT)

Private placement of common stock.

5S

$2.5

Miravant sold to unnamed private investors 5M unregistered shares of common stock for $2.5M at 50 cents per share (8/29)

Nymox Pharmaceuticals Corp. (NYMX)

Private placement of common stock

N/A

$0.763

Nymox raised $763,000 through private placements with existing shareholders (8/2)

Ortec International Inc. (ORTC)

Private placement of convertible preferred stock

N/A

$8.5

Ortec issued $8.5M of Series B convertible preferred stock (8/28)

Palatin Technologies Inc. (AMEX:PTN)

Private placement of common stock

2.6S

$4.2

Palatin raised $4.2M in the private placement; investors were SCOR Picking, Credit Suisse Equity Fund Global Biotech, Perceptive Life Sciences Fund, Albert Fried and Co. and Finedix BV (8/2)

Peregrine Pharmaceuticals Inc. (PPHM)

Private placement of common stock

N/A

$7.1

Peregrine raised $7.1M in two private placement arrangements with seven institutional investors (8/12)

Peregrine Pharmaceuticals Inc. (PPHM)

Private placement of common stock

2.9S

$1.9

Peregrine raised $1.9M through the sale of 2.9M shares to one institutional investor pursuant to a shelf registration (8/13)

Pheromone Sciences Corp. (Canada; TSE:PHS)

Private placement of common stock

1.3U

C$0.325 (US$0.208)

Pheromone completed a private placement of 1.3M units for gross proceeds of US$208,442 (8/16)

StemCells Inc. (STEM)

Private placement of common stock

1.03S

$1.1

StemCells raised $1.1M through a private place-ment with an institutional investor (8/28)

Notes:

This chart does not include real estate or manufacturing plant financings.

# Unless otherwise indicated, shares are traded on the Nasdaq exchange.

@ Dates refer to the date of the press release.

N/A = Not available, applicable or reported.

AMEX = American Stock Exchange; OTC BB = Over-the-Counter Bulletin Board; TSE = Toronto Stock Exchange